… BRAF(V600E) mutation is the most frequent genetic alteration in papillary thyroid carcinomas
(PTCs) that are 80–90% of all thyroid cancers. We evaluated the relationship between …

… of the BRAF V600E mutation was significantly associated with increased cancer-related …
was not independent of tumor features, how to use BRAF V600E to manage mortality risk in …

… In the present meta-analysis, the prevalence of LNM was increased in PTC patients with
BRAF V600E mutation which means BRAF V600E mutation was related to multifocality in PTC …

… found in papillary thyroid cancer (PTC). Recent studies show that this mutation occurs more
… evaluate the prevalence of the BRAF V600E mutation in tumor samples and its association …

… some have already proposed that BRAF V600E mutation detection be incorporated into the
… reexamine the association between BRAF V600E mutation and clinicopathological features …

… examination to label a papillary thyroid carcinoma (PTC) of 20 mm or less in size as a
pT1 or pT3 tumor. Objective: We correlated the BRAF V600E mutation with both clinical-…

… Background: The BRAF V600E mutation is the most frequent genetic alteration in papillary
thyroid carcinoma (PTC). The role of BRAF V600E mutation as a poor prognostic factor has …

… extension and foci of poorly/undifferentiated thyroid carcinoma [17]. In addition, we … BRAF
V600E mutation and engineered to express GFP (Green Fluorescent Protein) displays tumor …

… of the BRAF V600E mutation with cancer-specific mortality was not evaluated. To date,
Elisei et al reported increased mortality in those with the BRAF V600E mutation of 102 PTC …

… the mechanism of BRAFV600E mutation and … BRAFV600E mutation in preoperative diagnosis
and prognostic stratification, and recent advances in the use of the BRAFV600E mutation …